Top

Published in:

Open Access 23-02-2024 | Central Venous Catheter | Correspondence

Shorter time-to-positivity and turnaround time with mycosis blood culture bottles when detecting Candida albicans

Authors: Jacqueline Färber, Achim J. Kaasch, Enrico Schalk

Published in: Infection | Issue 2/2024

Excerpt

Candida spp. are human commensals and are commonly found on skin and throughout the gastrointestinal tract. Central venous catheters (CVC) and an immunocompromised state are major risk factors for candidemia [1, 2]. Thus, bloodstream infections (BSI) due to Candida spp. are more common in patients with hematological malignancies (1.4 vs. 0.83 cases/1,000 admissions) [2]. Candida BSI is associated with a higher 28-day all-cause mortality in hospitalized patients with hematological malignancies (45 vs. 11%) [2]. Early diagnosis, rapid initiation of appropriate treatment, and prompt source control (e.g. CVC removal) is key for reducing mortality in candidemia [3, 4]. …

Available only for authorised users

Pfaller M, Neofytos D, Diekema D, et al. Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance^®) registry, 2004–2008. Diagn Microbiol Infect Dis. 2012;74:323–31. https://doi.org/10.1016/j.diagmicrobio.2012.10.003.CrossRefPubMed

Gamaletsou MN, Walsh TJ, Zaoutis T, et al. A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies. Clin Microbiol Infect. 2014;20:O50–7. https://doi.org/10.1111/1469-0691.12312.CrossRefPubMed

Mikulska M, Del Bono V, Ratto S, Viscoli C. Occurrence, presentation and treatment of candidemia. Expert Rev Clin Immunol. 2012;8:755–65. https://doi.org/10.1586/eci.12.52.CrossRefPubMed

Mellinghoff SC, Cornely OA, Jung N. Essentials in Candida bloodstream infection. Infection. 2018;46:897–9. https://doi.org/10.1007/s15010-018-1218-1.CrossRefPubMed

Miller JM, Binnicker MJ, Campbell S, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. 2018;67:e1-94. https://doi.org/10.1093/cid/ciy381.CrossRefPubMed

Cobos-Trigueros N, Kaasch AJ, Soriano A, et al. Time to positivity and detection of growth in anaerobic blood culture vials predict the presence of Candida glabrata in candidemia: a two-center European cohort study. J Clin Microbiol. 2014;52:3082–4. https://doi.org/10.1128/JCM.01198-14.CrossRefPubMedPubMedCentral

Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52:e56-93. https://doi.org/10.1093/cid/cir073.CrossRefPubMed

Heinz WJ, Buchheidt D, Christopeit M, et al. Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol. 2017;96:1775–92. https://doi.org/10.1007/s00277-017-3098-3.CrossRefPubMedPubMedCentral

Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1–45. https://doi.org/10.1086/599376.CrossRefPubMed

10.

Böll B, Schalk E, Buchheidt D, et al. Central venous catheter-related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol. 2021;100:239–59. https://doi.org/10.1007/s00277-020-04286-x.CrossRefPubMed

11.

Rönnberg C, Mildh M, Ullberg M, Özenci V. Transport time for blood culture bottles: underlying factors and its consequences. Diagn Microbiol Infect Dis. 2013;76:286–90. https://doi.org/10.1016/j.diagmicrobio.2013.03.031.CrossRefPubMed

12.

Guo Z, Guo B, Wang S, Zhang H, Zhang W, Qin B, Shao H. Impact of satellite blood culture on early diagnosis of sepsis. J Intensive Med. 2021;2:56–60. https://doi.org/10.1016/j.jointm.2021.11.003.CrossRefPubMedPubMedCentral

13.

Köck R, Eißing LC, Boschin MG, Ellger B, Horn D, Idelevich EA, Becker K. Evaluation of bactec Mycosis IC/F and Plus Aerobic/F blood culture bottles for detection of Candida in the presence of antifungal agents. J Clin Microbiol. 2013;51:3683–7. https://doi.org/10.1128/JCM.02048-13.CrossRefPubMedPubMedCentral

14.

Laroche L, Mercier V, Sasso M. BD BACTEC™ Mycosis IC/F culture vials for fungemia diagnosis and follow-up: a retrospective study from 2013 to 2020. Diagn Microbiol Infect Dis. 2023;105: 115863. https://doi.org/10.1016/j.diagmicrobio.2022.115863.CrossRefPubMed

15.

Arendrup MC, Bruun B, Christensen JJ, et al. National surveillance of fungemia in Denmark (2004 to 2009). J Clin Microbiol. 2011;49:325–34. https://doi.org/10.1128/JCM.01811-10.CrossRefPubMed

Title: Shorter time-to-positivity and turnaround time with mycosis blood culture bottles when detecting Candida albicans
Authors: Jacqueline Färber
Achim J. Kaasch
Enrico Schalk
Publication date: 23-02-2024
Publisher: Springer Berlin Heidelberg
Keywords: Central Venous Catheter
Candida Albicans
Candida Balanitis
Published in: Infection / Issue 2/2024
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI: https://doi.org/10.1007/s15010-024-02216-x

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2024

Sex differences in infective endocarditis: a Danish nationwide study

Population of invasive group A streptococci isolates from a German tertiary care center is dominated by the hypertoxigenic virulent M1UK genotype

Self-sampled multi-anatomic site testing for uncovering the community burden of undiagnosed Chlamydia trachomatis and Neisseria gonorrhoeae infection in men who have sex with men

Odontogenic infections in the antibiotic era: approach to diagnosis, management, and prevention

Understanding the biases to sepsis surveillance and quality assurance caused by inaccurate coding in administrative health data

Blood T cell phenotypes correlate with fatigue severity in post-acute sequelae of COVID-19

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage